These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 3272130)
1. Analytical solution to the three-compartment pharmacokinetic model. Jacobs JR IEEE Trans Biomed Eng; 1988 Sep; 35(9):763-5. PubMed ID: 3272130 [No Abstract] [Full Text] [Related]
2. Comments on "Analytical Solution to the Three-Compartment Pharmacokinetic Model". Larsen JL; Arzbaecher R IEEE Trans Biomed Eng; 1989 Nov; 36(11):1141-2. PubMed ID: 2807324 [No Abstract] [Full Text] [Related]
3. The hybrid model: a new pharmacokinetic model for computer-controlled infusion pumps. Wada DR; Ward DS IEEE Trans Biomed Eng; 1994 Feb; 41(2):134-42. PubMed ID: 8026846 [TBL] [Abstract][Full Text] [Related]
4. [Computerized determination of pharmacokinetic constants in a biocompartmental model aimed at the optimal clinical use of drugs]. Zatelli R; Camerini G; Tonini P; Voghenzi A Boll Soc Ital Biol Sper; 1989 Jun; 65(6):529-34. PubMed ID: 2611014 [TBL] [Abstract][Full Text] [Related]
5. Use of a simulated annealing algorithm to fit compartmental models with an application to fractal pharmacokinetics. Marsh RE; Riauka TA; McQuarrie SA J Pharm Pharm Sci; 2007; 10(2):168-79. PubMed ID: 17706176 [TBL] [Abstract][Full Text] [Related]
6. Estimation of pharmacokinetic parameters from non-compartmental variables using Microsoft Excel. Dansirikul C; Choi M; Duffull SB Comput Biol Med; 2005 Jun; 35(5):389-403. PubMed ID: 15767115 [TBL] [Abstract][Full Text] [Related]
7. Extended kalman filtering for the modeling and analysis of ICG pharmacokinetics in cancerous tumors using NIR optical methods. Alacam B; Yazici B; Intes X; Chance B IEEE Trans Biomed Eng; 2006 Oct; 53(10):1861-71. PubMed ID: 17019849 [TBL] [Abstract][Full Text] [Related]
8. A simple pharmacokinetics subroutine for modeling double peak phenomenon. Mirfazaelian A; Mahmoudian M Biopharm Drug Dispos; 2006 Apr; 27(3):119-24. PubMed ID: 16400712 [TBL] [Abstract][Full Text] [Related]
9. Experimental design for regression analysis when the responses are subject to censoring. Han C Comput Methods Programs Biomed; 2007 Aug; 87(2):104-11. PubMed ID: 17566594 [TBL] [Abstract][Full Text] [Related]
10. On nonoscillation and monotonicity of solutions of nonnegative and compartmental dynamical systems. Chellaboina V; Haddad WM; Bailey JM; Ramakrishnan J IEEE Trans Biomed Eng; 2004 Mar; 51(3):408-14. PubMed ID: 15000372 [TBL] [Abstract][Full Text] [Related]
11. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a). Usansky HH; Sinko PJ J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900 [TBL] [Abstract][Full Text] [Related]
12. Prediction discrepancies for the evaluation of nonlinear mixed-effects models. Mentré F; Escolano S J Pharmacokinet Pharmacodyn; 2006 Jun; 33(3):345-67. PubMed ID: 16284919 [TBL] [Abstract][Full Text] [Related]
13. Application of direct search optimization for pharmacokinetic parameter estimation. Khorasheh F; Sattari S; Gerayeli A; Ahmadi AM J Pharm Pharm Sci; 1999; 2(3):92-8. PubMed ID: 10953255 [TBL] [Abstract][Full Text] [Related]
14. Definition and determination of important pharmacokinetic parameters for dosage regimen (one compartment model). Seydel JK Eur J Toxicol Hyg Environ; 1972; 5(5 Suppl):53-61. PubMed ID: 14732951 [No Abstract] [Full Text] [Related]
15. In vivo simulation of human pharmacokinetics in the rabbit. Bugnon D; Potel G; Caillon J; Baron D; Drugeon HB; Feigel P; Kergueris MF Bull Math Biol; 1998 May; 60(3):545-67. PubMed ID: 9608855 [TBL] [Abstract][Full Text] [Related]
16. Minimal experimental requirements for structural identifiability in linear compartmental models. The software 'IDEXMIN'. Mérino JA; de Biasi J; Plusquellec Y; Houin G Arzneimittelforschung; 1996 Mar; 46(3):324-8. PubMed ID: 8901159 [TBL] [Abstract][Full Text] [Related]
17. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy. Ledzewicz U; Schättler H Math Biosci; 2007 Apr; 206(2):320-42. PubMed ID: 16197967 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates. Kortejärvi H; Urtti A; Yliperttula M Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967 [TBL] [Abstract][Full Text] [Related]
20. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study. Kuentz M; Nick S; Parrott N; Röthlisberger D Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]